India’s Biologics Market To Hit $12 Billion By 2025 – Reports

Biologics and Biosimilars Industry in India is Growing Faster Than
Ever. India, now the emerging hub for biosimilars and biologics,
always possessed the skills to work on small molecules required to
make generic drugs. Still, they lacked the skills and environment to
develop reverse-engineered versions of biotech drugs. However, the
launch of 123 biosimilars, in […]

The post India's Biologics Market To Hit $12 Billion By 2025 – Reports
appeared first on BioTecNika .

https://www.biotecnika.org/2019/12/biologics-and-biosimilars-industry-in-india-is-growing-faster-than-ever/

Biotech News

Comments

Popular posts from this blog

NISER PhD Program Admission 2020-21 (Winter Session)

Data Analyst Jobs – Life Sciences Apply at Cognizant

Are hospitals prescribing the more expensive remdesivir instead of cheaper alternatives?